Characterisation of excitatory and inhibitory transmitter systems in prostate glands of rats, guinea pigs, rabbits and pigs

European Journal of Pharmacology

Volumn 337, Issue 2-3, 1997, Pages 251-258

  Najbar Kaszkiel, Alicja T ^a   Di Iulio, Juliana L ^a   Li, Chun Guang ^a   Rand, Michael J ^a  

^a Dept Med Lab Sci Roy M   (Australia)

Author keywords

Guinea pig; NANC (non adrenergic non cholinergic) innervation; Nitrergic innervation; Noradrenergic innervation; Pig; Prostate gland; Rabbit; Rat

Indexed keywords

ATROPINE; GUANETHIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC INNERVATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; GUINEA PIG; INNERVATION; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROSTATE; RABBIT; SWINE;

ANIMALS; ELECTRIC STIMULATION; GUINEA PIGS; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; PROSTATE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; SWINE; SYNAPTIC TRANSMISSION;

EID: 0030714577     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01270-3     Document Type: Article

References (38)

1. Addicks, K., Klotz, T., Loch, C., Schmidt, U., Bloch, W., 1996. Localisation of nitric oxide synthase in the human prostate: Histochemical and immunohistochemical study using light and electromicroscopical techniques. In: Moncada, S., Stamler, J., Gross, S., Higgs, E.A. (Eds.), Biology of Nitric Oxide. Portland Press, London, p. 242.
2. Aikawa K., Yamaguchi O., Yokota T., Shiraiwa Y. The involvement of the L-arginine/nitric oxide pathway in rabbit prostatic smooth muscle. Neurourol. Urodyn. 13:1994;399-400.
3. G-nitro-arginine on sympathetic nerve induced contraction and noradrenaline release in the rat isolated anococcygeus muscle. J. Auton. Pharmacol. 13:1993;219-225.
4. Burnett A.L. Nitric oxide control of lower genitourinary tract functions: A review. Urology. 45:1995;1071-1083.
5. Burnett A.L., Lowenstein C.J., Bredt D.S., Chang T.S., Snyder S.H. Nitric oxide: A physiological mediator of penile erection. Science. 257:1992;401-403.
6. Burnett A.L., Tillman S.L., Chang T.S.K., Epstein J.I., Lowenstein C.J., Bredt D.S., Snyder S.H., Walsh P.C. Immunohistochemical localisation of nitric oxide synthase in the autonomic innervation of the human penis. J. Urol. 150:1993;73-76.
7. Burnett A.L., Maguire M.P., Chamness S.L., Ricker D.D., Takeda M., Lepor H., Chang T.S.K. Characterisation and localisation of nitric oxide synthase in the human prostate. Urology. 45:1995;435-439.
8. Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J. Urol. 136:1986;1-4.
9. Caine M., Raz S., Zeigler M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br. J. Pharmacol. 47:1975;193-202.
10. Chapple C.R., Christmas T.J., Milroy E.J.G. A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction. Urol. Int. 45:1990;47-55.
11. 1-adrenoceptor. Br. J. Pharmacol. 119:1996;1093-1100.
12. Chueh S.C., Guh J.H., Chen J., Lai M.K., Ko F.N., Teng C.M. Inhibition by tamsulosin of tension responses of human hyperplastic prostate to electrical field stimulation. Eur. J. Pharmacol. 305:1996;177-180.
13. Cohen M.L., Drey K. Contractile responses in bladder body, bladder neck and prostate from rat, guinea pig and cat. J. Pharmacol. Exp. Ther. 248:1989;1063-1068.
14. Di Iulio J.L., Gude N.M., King R.G., Brennecke S.P. Human placental and fetal membrane nitric oxide synthase activity before, during and after labour at term. Reprod. Fertil. Dev. 7:1996;1505-1508.
15. Di Iulio J.L., Li C.G., Rand M.J. Characterisation of enzymes that convert L-arginine to L-citrulline in the rat, pig and rabbit prostate glands. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 3:1996;85P.
16. Ehrén I., Adolfsson J., Wiklund N.P. Nitric oxide synthase activity in the human urogenital tract. Urol. Res. 22:1994;287-290.
17. Ehrén, I., Hammerström, M., Adolfsson, J., Wiklund, N.P., 1996. Nitric oxide synthase activity in the urogenital tract. In: Moncada, S., Stamler, J., Gross, S., Higgs, E.A. (Eds.), Biology of Nitric Oxide. Portland Press, London, p. 243.
18. Feelish M. The biochemical pathways of nitric oxide formation from nitrovasodilators: Appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17:1991;S25-S33.
19. Garraway W.M., Collins G.N., Lee R.J. High prevalence of benign prostatic hypertrophy in the community. Lancet. 338:1991;469-4741.
20. Gibson A., Gillespie J.S. The effect of immunosympathectomy and 6-hydroxydopamine on the responses of the rat anococcygeus to nerve stimulation and to some drugs. Br. J. Pharmacol. 47:1973;261-267.
21. Gillespie J.S. The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br. J. Pharmacol. 45:1972;404-416.
22. Hedlund P., Ekström P., Larsson B., Alm P., Andersson K.E. Heme oxygenase and NO-synthase in the human prostate - Relation to adrenergic, cholinergic and peptide-containing nerves. J. Auton. Nerv. Syst. 63:1997;115-126.
23. Hieble J.P., Caine M., Zalaznick E. In vitro characterisation of the alpha-adrenoceptors in human prostate. Eur. J. Pharmacol. 107:1985;111-117.
24. Hieble J.P., Boyce A.J., Caine M. Comparison of the α-adrenoceptor characteristics in human and canine prostate. Fed. Proc. 45:1986;2609-2613.
25. 1-adrenoceptor subtypes in the rabbit prostate. J. Auton. Pharmacol. 15:1996;271-278.
26. Kunisawa Y., Kawabe K., Niijima T., Honda K., Takenaka T. A pharmacological study of alpha adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra. J. Urol. 134:1985;396-398.
27. Li C.G., Rand M.J. Evidence for the role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clin. Exp. Pharmacol. Physiol. 16:1989;933-938.
28. 1C-) adrenoceptor subtype. Br. J. Pharmacol. 115:1995;781-786.
29. 1-adrenoceptor subtypes and in human prostate. J. Auton. Pharmacol. 16:1996;21-28.
30. Najbar-Kaszkiel A.T., Li C.G., Rand M.J. Characterisation of transmitter systems in isolated prostate glands of rats, guinea-pigs, pigs and rabbits. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 3:1996;184P.
31. 1-adrenoceptor subtype mRNAs in human prostate: Comparison of benign hypertrophied tissue and non-hypertrophied tissue. Br. J. Pharmacol. 119:1996;797-803.
32. Normandin D.E., Lodge N.J. Pharmacological characterisation of the isolated canine prostate. J. Urol. 155:1996;1758-1761.
33. Oesterling J.E. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. New Engl. J. Med. 332:1995;99-109.
34. Price D.T., Schwinn D.A., Lomasney J.W., Allen L.F., Caro M.G., Lefkowitz R.J. Identification, quantification and localisation of mRNA for three distinct alpha1 adrenergic receptor subtypes in human prostate. J. Urol. 150:1993;546-551.
35. Raz S., Zeigler M., Caine M. Pharmacological receptors in the prostate. Br. J. Urol. 45:1973;663-667.
36. Takeda M., Tang R., Shapiro E., Burnett A.L., Lepor H. Effects of nitric oxide on human and canine prostates. Urology. 45:1995;440-446.
37. 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man. Eur. J. Pharmacol. 249:1993;307-315.
38. 1C-adrenoceptor in human prostate: Cloning, functional expression, and localisation to specific prostatic cell types. Br. J. Pharmacol. 115:1995;1475-1485.